NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

The only problem is no big pharma is interested in partnering. If they were, we would have seen a combo trial deal announced by now. Nature article around combo efficacy is already out and TLD, JAMA have been out for 2 years as well. Share price has nothing to do with a non dilutive combo trial partnership, where big pharma would get exclusive rights to sell in the chosen indication. In fact, the share price would jump massively if such a deal was announced.

Also, Flaskworks is irrelevant for combo trial partnership. They can run a trial with manual method and transition to Flaskworks for commercial
production after a successful trial. Similar to how they ran GBM phase 3 trial. Flaskworks is not going to be ready to be deployed in clinical trials for another year. Commercial approval will likely take 2 years or more.